Visalytics
Visalytics
approved EB-2 (NIW)

Associate Professor

Pharmaceutical Sciences · Pakistan · 2025-04-15

Processing Time
487 days
Decision Date
2025-04-15
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to design natural compound-based therapeutics using computer-aided drug discovery to treat Type 1 diabetes and neurological disorders. This work focuses on developing non-synthetic therapeutic options for inflammation-related disorders, chronic pain, and systemic conditions using bioactive compounds from traditional medicinal plants. The endeavor aims to improve patient outcomes and address significant public health concerns in the United States.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses significant public health concerns such as diabetes and neurological disorders through innovative drug discovery.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 100 publications, 3,400 citations, and international funding demonstrates a high level of expertise and influence.

3 Balance of Interests Met

The petitioner's unique skills in natural product pharmacology make it beneficial to the U.S. to waive the job offer requirement.

Why This Petition Was Approved

The petition was approved based on a robust record of nearly 100 peer-reviewed journal articles and over 3,400 citations, with many papers ranked among the most-cited in the field. The petitioner also demonstrated leadership through 19 verified peer review assignments and editorial board memberships for reputable journals. The case was supported by two independent expert letters and evidence of research funding from major international and government agencies, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Professional Memberships
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Research and Development · Nigeria

WeGreened EB-2 (NIW) approved
South Africa 74 days 2023-02-27
The petitioner proposes to identify natural product drug candidates to develop therapeutics for the management of degenerative diseases such as cancer, diabetes mellitus, and HIV/AIDS. The work focuses on reducing the prevalence of these conditions through molecular biology-related DNA quantification and sequencing of indigenous medicinal plants.
View Case

Postdoctoral Researcher

Pharmaceuticals · Vietnam

WeGreened EB-2 (NIW) approved
278 days 2025-01-11
The petitioner proposes to identify and analyze novel bioactive compounds isolated from natural sources with distinct chemical diversity. This work aims to accelerate the development of new pharmaceuticals for chronic diseases that currently lack adequate treatments, such as diabetes, cardiovascular disease, and osteoporosis.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Tennessee 184 days 2022-10-04
The petitioner proposes to continue his research on the isolation and characterization of naturally sourced bioactive pharmacological compounds. This work focuses on developing new preventative and curative therapies for disorders such as diabetes mellitus, diabetic gastroparesis, and anxiety disorders.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from Pakistan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-15.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 487 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Pakistan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist